Fingerprint
Dive into the research topics of 'Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically